![logo](/logos/IONS.webp)
Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
46.89 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Ionis Pharmaceuticals, Inc. |
Symbool | IONS |
Munteenheid | USD |
Prijs | 46.89 |
Beurswaarde | 6,855,833,790 |
Dividendpercentage | 0% |
52-weken bereik | 35.95 - 54.44 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Brett P. Monia Ph.D. |
Website | https://www.ionispharma.com |
An error occurred while fetching data.
Over Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)